Truncated thioredoxin (Trx80) induces differentiation of human CD14+ monocytes into a novel cell type (TAMs) via activation of the MAP kinases p38, ERK, and JNK. (Q45115070)
Jump to navigation
Jump to search
scientific article published on 19 October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Truncated thioredoxin (Trx80) induces differentiation of human CD14+ monocytes into a novel cell type (TAMs) via activation of the MAP kinases p38, ERK, and JNK. |
scientific article published on 19 October 2004 |
Statements
1 reference
Truncated thioredoxin (Trx80) induces differentiation of human CD14+ monocytes into a novel cell type (TAMs) via activation of the MAP kinases p38, ERK, and JNK. (English)
1 reference
Annika Scheynius
1 reference
Klas Pekkari
1 reference
Mohammad Taghi Goodarzi
1 reference
Arne Holmgren
1 reference
Javier Avila-Cariño
1 reference
19 October 2004
1 reference
Identifiers
1 reference